Enlivex Financial Statements From 2010 to 2024
| ENLV Stock | ILA 372.90 4.90 1.33% |
Check Enlivex Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Enlivex Therapeutics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Enlivex financial statements analysis is a perfect complement when working with Enlivex Therapeutics Valuation or Volatility modules.
Enlivex |
Enlivex Therapeutics Company Shares Outstanding Analysis
Enlivex Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Enlivex Therapeutics Shares Outstanding | 18.41 M |
Most of Enlivex Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enlivex Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Enlivex Therapeutics has 18.41 M of shares currently outstending. This is 89.8% lower than that of the Healthcare sector and 82.77% lower than that of the Biotechnology industry. The shares outstanding for all Israel stocks is 96.78% higher than that of the company.
Enlivex Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Enlivex Therapeutics's current stock value. Our valuation model uses many indicators to compare Enlivex Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enlivex Therapeutics competition to find correlations between indicators driving Enlivex Therapeutics's intrinsic value. More Info.Enlivex Therapeutics is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Enlivex Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Enlivex Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Enlivex Therapeutics Financial Statements
Enlivex Therapeutics stakeholders use historical fundamental indicators, such as Enlivex Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Enlivex Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Enlivex Therapeutics' assets and liabilities are reflected in the revenues and expenses on Enlivex Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Enlivex Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. ENLIVEX THERAPEUTI operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 50 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Enlivex Stock
When determining whether Enlivex Therapeutics is a strong investment it is important to analyze Enlivex Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Enlivex Therapeutics' future performance. For an informed investment choice regarding Enlivex Stock, refer to the following important reports:Check out the analysis of Enlivex Therapeutics Correlation against competitors. For information on how to trade Enlivex Stock refer to our How to Trade Enlivex Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.